Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein

Infection and Immunity

Volumn 66, Issue 2, 1998, Pages 486-491

  Elass Rochard, Elisabeth ^a   Legrand, Dominique ^a   Salmon, Valerie ^a   Roseanu, Anca ^b   Trif, Mihaela ^b   Tobias, Peter S ^c   Mazurier, Joel ^a   Spik, Genevieve ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^b INSTITUTE OF BIOCHEMISTRY OF THE ROMANIAN ACADEMY   (Romania)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD14 ANTIGEN; ESCHERICHIA COLI ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLYCOPROTEIN; LACTOFERRIN;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENDOTOXEMIA; ESCHERICHIA COLI; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEPTIC SHOCK;

ACUTE-PHASE PROTEINS; ANTIGENS, CD14; BINDING, COMPETITIVE; CARRIER PROTEINS; CELL LINE; HUMANS; LACTOFERRIN; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MONOCYTES;

EID: 0031883875     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.2.486-491.1998     Document Type: Article

References (53)

1. Abrahamson, S. L., H. S. Wu, R. E. Williams, K. Der, N. Ottah, R. Little, H. Gazzano-Santoro, G. Theofan, R. Bauer, S. Leigh, A. Orme, A. H. Horwitz, S. F. Caroll, and R. L. Dedrick. 1997. Biochemical characterization of recombinant fusions of LPS-binding protein and bactericidal/permeabilityincreasing protein. J. Biol. Chem. 272:2149-2155.
2. Andersen, B. F., H. M. Baker, G. E. Norris, D. W. Rice, and E. N. Baker. 1989. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 Å resolution. J. Mol. Biol. 209:711-734.
3. Appelmelk, B. J., Y. Q. An, M. Geerts, B. G. Thijs, H. A. De Boer, D. M. MacLaren, J. De Graaff, and J. H. Nuijens. 1994. Lactoferrin is a lipid A binding protein. Infect. Immun. 62:2628-2632.
4. Bellamy, W., M. Takase, K. Vamauchi, H. Wakabayashi, K. Kawase, and M. Tomita. 1992. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121:130-136.
5. Brock, J. 1986. Iron and cells of the immune system, p. 81-98. In M. de Souza and J. Brock (ed.), Iron in immunity, cancer and inflammation. John Wiley and Sons, Chichester, England.
6. Cohen, M. S., J. Mao, G. T. Rasmusen, J. S. Serody, and B. E. Britigan. 1992. Interaction of lactoferrin and lipopolysaccharide: effects on the antioxidant property of lactoferrin and the ability of lipopolysaccharide to prime human neutrophils for enhanced Superoxide anion. J. Infect. Dis. 166:1375-1378.
7. Crouch, S. M., K. J. Slater, and J. Fletcher. 1992. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80:235-240.
8. Dentener, M. A., E. J. U. von Asmuth, G. J. M. Fraucot, M. N. Marra, and W. A. Buurman. 1993. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/increasing permeability protein on LPS induced cytokine release by mononuclear phagocytes. J. Immunol. 151:4258-4265.
9. Elass, A., G. Vergoten, D. Legrand, J. Mazurier, E. Elass-Rochard, and G. Spik. 1996. Processes underlying interactions of human lactoferrin with the Jurkat human lymphoblastic T-cell line receptor. I. Quantitative structure affinity relationships studies. Quant. Struct. Act. Relat. 15:95-101.
10. Elass, A., G. Vergoten, D. Legrand, J. Mazurier, E. Elass-Rochard, and G. Spik. 1996. Processes underlying interactions of human lactoferrin with the Jurkat human lymphoblastic T-cell line receptor. II. Comparative molecular field analysis. Quant. Struct. Act. Relat. 15:102-107.
11. Elass-Rochard, E., A. Roseanu, D. Legrand, M. Trif, V. Salmon, C. Motas, J. Montreuil, and G. Spik. 1995. Lactoferrin-LPS interactions: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055:B5 lipopolysaccharides. Biochem. J. 312:839-845.
12. Gazzano-Santoro, H., J. B. Parent, P. J. Conlon, H. G. Kasler, C. M. Tsai, D. A. Lill-Elghanian, and R. I. Hollingsworth. 1995. Characterization of the structural elements in lipid A required for binding of a recombinant fragment of bactericidal/permeability-increasing protein. Infect. Immun. 63:2201-2205.
13. Gray, P. W., G. Flaggs, S. R. Leong, R. J. Gumina, J. Weiss, C. E. Ooi, and P. Elsbach. 1989. Cloning of the cDNA of a human neutrophil bactericidal protein-structure and functional correlations. J. Biol. Chem. 264:9505-9509.
14. Han, J., J. Mathison, R. Ulevitch, and P. S. Tobias. 1994. Lipopolysaccharide binding protein truncated at Ile-197 binds LPS but does not transfer LPS to CD14. J. Biol. Chem. 269:8172-8177.
15. Hoess, A., S. Watson, G. R. Siber, and R. Liddington. 1993. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5Å resolution. EMBO J. 12:3351-3356.
16. Kirkland, T. N., F. Finley, D. Letureq, A. Moriarty, J. D. Lee, R. J. Ulevitch, and P. S. Tobias. 1993. Analysis of lipopolysaccharide binding to CD14. J. Biol. Chem. 268:24818-24823.
17. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of hacteriophagc T4. Nature 227:680-685.
18. Legrand, D., J. Mazurier, A. Elass, E. Rochard, G. Vergoten, P. Maes, J. Montreuil, and G. Spik, 1992. Molecular interactions between human lactoferrin and the PHA-activated human lymphocyte lactoferrin receptor lie in the two loop containing regions of the N-terminal domain I of human lactoferrin. Biochemistry 31:9243-9251.
19. Legrand, D., V. Salmon, B. Coddeville, M. Benaissa, Y., Plancke, and G. Spik. 1995. Structural determination of two N-linked glycans isolated from recombinant human lactoferrin expressed in BHK cells. FEES Lett. 365:57-60.
20. Legrand, D. L., P. H. C. van Berkel, V. Salmon, H. A. van Veen, M. C. Slomianny, J. H. Nuijens, and G. Spik. 1997. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulfated molecules but not with the receptor expressed in the Jurkat human lymphoblastic T-cells. Biochem. J. 327:841-546.
21. Little, R. G., D. N. Kelner, E. Lim, D. J. Burke, and P. J. Colon. 1994. Functional domains of recombinant bactericidal/increasing permeability protein (rBPI23). J. Biol. Chem. 269:1865-1872.
22. Machnicki, M., M. Zimecki, and T. Zagulski. 1993. Lactoferrin regulates the release of tumor necrosis factor α, Il-6 in vivo. J. Exp. Pathol. 74:433-439.
23. Mann, D. M., E. Romm, and M. Migliorini. 1994. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 269:23661-23667.
24. Martin, T. R., J. C. Mathison, P. S. Tobias, D. J. Letureq, A. M. Moriarty, R. J. Maunder, and R. J. Ulevitch. 1992. Lipopolysaccharide-binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide: implications for cytokine production in normal and injured lungs, J. Clin. Invest. 90:2209-2219.
25. Masson, P. L., J. F. Heremans, and E. Schönne. 1969. Lactoferrin an iron binding protein in neutrophilic leukocytes. J. Exp. Med. 130:643-656.
26. Mathison, J. C., P. S. Tobias, E. Wolfson, and R. J. Ulevitch. 1992. Plasma LPS binding protein, a key component in macrophage recognition of gram (-) LPS. J. Immunol. 194:200-206.
27. Mattsby-Baltzer, I., A. Roseanu, C. Motas, J. Elverfors, I. Engberg, and L. A. Hanson. 1996. Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin 6 response in human monocytic cells. Pediatr. Res. 40:257-261.
28. Mazurier, J., D. Legrand, W. L. Hu, J. Montreuil, and G. Spik. 1989. Expression of human lactoferrin receptors in PHA-stimulated human peripheral blood lymphocytes: isolation of the receptors by anti-ligand affinity chromatography. Eur. J. Biochem. 179:481-487.
29. Mazurier, J., and G. Spik. 1980. Comparative study of the iron-binding properties of human transferrins. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim. Biophys. Acta 629:399- 408.
30. Montreuil, J., J. Tonnelat, and S. Mullet. 1960. Préparation et propriétés de la lactotransferrine du lait de femme. Biochim. Biophys. Acta 45:413-421.
31. Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharide. Immunochemistry 13:813-818.
32. Muta, T., T. Miyata, F. Tokunaga, T. Nakamura, and S. Iwanaga. 1987. Primary structure of anti-LPS factor from American horseshoe crab, Limu- lus polyphenus. J. Biochem. 101:1321-1330.
33. Ohno, N., and D. C. Morrison. 1989. Lipopolysaccharide interaction with lysozyme. J. Biol. Chem. 264:4434-4441.
34. Parillo, J. E. 1993. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1471-1477.
35. Salmon, V., D. Legrand, B. Georges, M. C. Slomianny, B. Coddeville, and G. Spik. 1996. Characterization of human lactoferrin produced in the baculo-virus expression system. Protein Express. Purif. 9:203-210.
36. Sanchez, L., M. Calvo, and J. H. Brock, 1992. Biological role of lactoferrin. Arch. Dis. Child. 67:657-661.
37. Schumann, R. R., S. R. Leung, G. W. Flaggy P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of LPS-binding protein. Science 249:1429-1433.
38. Spik, G., G. Strecker, B. Fournet, S. Bouquelet, J. Montreuil, L. Dorland, H. van Halbeek, and J. F. G. Vliegenthart. 1982. Primary structure of the glycans from human lactotransfcrrin. Eur. J. Biochem. 121:413-419.
39. Taylor, A. H., G. Heauner, M. Nedelman, D. Sherris, E. Brunt, D. Knight, and J. Ghrayeb, 1995. Lipopolysaccharide neutralizing peptides reveal a lipid A binding site of LPS binding protein. J. Biol. Chem. 270:17934-17938.
40. Theofan, G., A. H. Horwitz, R. E. Williams, P. S. Liu, I. Chan, C. Birr, S. F. Carroll, K. Meszaros, J. B. Parent, H. Kasler, S. Aberle, P. W. Trown, and H. Gazzano-Santoro. 1994. An amino-terminal fragment of human LPS-binding protein retains lipid A binding but not CD14-stimulatory activity. J. Immunol. 152:3623-3629.
41. Tobias, P. S., J. C. Mathison, and R. J. Ulevitch. 1988. A family of LPS-binding proteins involved in responses to gram (-) sepsis. J. Biol. Chem. 263:13479-13481.
42. Tobias, P. S., K. Soldau, and R. J. Ulevitch. 1986. Isolation of a LPS binding acute phase reactant from rabbit serum. J. Exp. Med. 164:777-793.
43. Tobias, P. S., K. Soldau, and R. J. Ulevitch. 1989. Identification of a lipid A binding site in the acute phase reactant LPS binding protein. J. Biol. Chem. 264:10867-10871.
44. Tomita, M., M. Takase, W. Bellamy, and S. Shimamura. 1994. A review: the: active peptide of lactoferrin. Acta Paed. Japonica. 36:585-591.
45. Trumpler, U. P., W. Straub, and A. Rosenmund. 1989. Antibacterial prophylaxis with lactoferrin in neutropaenic patients. Eur. J. Clin. Microbiol Infect. Dis. 8:310-318.
46. Ulevitch, R. J. 1993. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv. Immunol. 53:267-289.
47. Ulevitch, R. J., and P. S. Tobias. 1994. Recognition of endotoxin by cells leading to transmembrane signalling. Curr. Opin. Immunol. 6:125-130.
48. Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437-457.
49. 2VitD3 induce on THP-1 cells distinct patterns of cell surface antigen expression. Cytokine production and responsiveness to contact with activated T cells. J. Immunol. 149:2040-2046.
50. Wang, D., K. M. Pabst, Y. Aida, and M. J. Pabst. 1995. Lipopolysaccharide-inactivating activity of neutrophils is due to lactoferrin. J. Leukocyte Biol. 57:865-874.
51. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J., Ulevitch, and J. C., Mathison. 1990. CD14 serves as the cellular receptor for complexes of LPS with LPS binding protein. Science 249:1431-1433.
52. Zagulski, T., P. Lipinski, A. Zagulska, S. Broniek, Z. Jarzabek. 1989. Lactoferrin can protect mice against a lethal dose of Eschenchia coli in experimental infection in vivo. Br. J. Exp. Pathol. 70:697-704.
53. Zimecki, M., J. Mazurier, M. Machnicki, Z. Wieczorek, J. Montreuil, and G. Spik. 1991. Immunostimulatory activity of lactoferrin and maturation of CD4(-)-CD8(-) murine thymocytes. Immunol. Lett. 30:377-382.